Insulin Delivery Into the Peripheral Circulation: A Key Contributor to Hypoglycemia in Type 1 Diabetes.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMID 26085570)

Published in Diabetes on June 17, 2015

Authors

Justin M Gregory1, Guillaume Kraft2, Melanie F Scott2, Doss W Neal2, Ben Farmer2, Marta S Smith2, Jon R Hastings2, Eric J Allen2, E Patrick Donahue2, Noelia Rivera2, Jason J Winnick2, Dale S Edgerton2, Erica Nishimura3, Christian Fledelius3, Christian L Brand3, Alan D Cherrington2

Author Affiliations

1: Ian M. Burr Division of Pediatric Endocrinology and Diabetes, Vanderbilt University School of Medicine, Nashville, TN justin.m.gregory.1@vanderbilt.edu.
2: Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN.
3: Novo Nordisk, Copenhagen, Denmark.

Articles cited by this

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med (2004) 10.35

Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J Pediatr (1994) 8.78

Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia (2002) 6.00

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med (2003) 5.87

Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985) (2000) 5.24

The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care (2009) 4.93

Hepatic vascular bed. Physiol Rev (1971) 3.11

Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science (1973) 2.99

Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group. JAMA (1996) 2.94

Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest (1993) 2.35

Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J Clin Endocrinol Metab (2009) 2.01

Blunted counterregulatory hormone responses to hypoglycemia in young children and adolescents with well-controlled type 1 diabetes. Diabetes Care (2009) 2.01

Orchestration of glucose homeostasis: from a small acorn to the California oak. Diabetes (2007) 1.95

Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes (2010) 1.80

Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med (1997) 1.77

Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes: results from the Yorkshire Register of diabetes in children and young adults. Diabetes Care (2008) 1.66

Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus. Pediatrics (2005) 1.63

Blood flows within and among rat muscles as a function of time during high speed treadmill exercise. J Physiol (1983) 1.59

A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes (1996) 1.53

Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients. Diabetes (1990) 1.47

Insulin's direct effects on the liver dominate the control of hepatic glucose production. J Clin Invest (2006) 1.43

Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration. J Clin Invest (1991) 1.22

Association between glycosylated hemoglobin level and cardiovascular and all-cause mortality in type 1 diabetes. Am J Epidemiol (2007) 1.22

Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes. J Clin Endocrinol Metab (2012) 1.20

Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism. Diabetes (2001) 1.19

Diabetic complications. The importance of glucose control. Endocrinol Metab Clin North Am (1996) 1.11

Comparison of peripheral and portal (via the umbilical vein) routes of insulin infusion in IDDM patients. Diabetes (1992) 1.07

A circulatory model for calculating non-steady-state glucose fluxes. Validation and comparison with compartmental models. Comput Methods Programs Biomed (2003) 1.07

Compartmental modeling of glucagon kinetics in the conscious dog. Metabolism (1995) 1.05

Early loss of the glucagon response to hypoglycemia in adolescents with type 1 diabetes. Diabetes Care (2012) 1.04

Morbidity of hypoglycemia in type 1 diabetes. Diabetes Res Clin Pract (2004) 0.96

A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion. Diabetes Obes Metab (2009) 0.96

A negative arterial-portal venous glucose gradient increases net hepatic glucose uptake in euglycemic dogs. Am J Physiol (1999) 0.94

A physiological increase in the hepatic glycogen level does not affect the response of net hepatic glucose uptake to insulin. Am J Physiol Endocrinol Metab (2009) 0.93

Pulsatility does not alter the response to a physiological increment in glucagon in the conscious dog. Am J Physiol (1994) 0.93

Diabetic nephropathy in children and adolescents. Pediatr Nephrol (2007) 0.92

Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog. Am J Physiol Endocrinol Metab (2007) 0.91

Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious dogs. Diabetes (1988) 0.90

Fluorescence microscopical and chemical characterization of the adrenergic innervation in mammalian liver tissue. Cell Tissue Res (1983) 0.86

Effects of insulin deficiency or excess on hepatic gluconeogenic flux during glycogenolytic inhibition in the conscious dog. Diabetes (2002) 0.85

Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro. J Clin Endocrinol Metab (1984) 0.85

Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes. Metabolism (2002) 0.82

Changes in glucose and fat metabolism in response to the administration of a hepato-preferential insulin analog. Diabetes (2014) 0.82

Local oxygen supply and blood flow regulation in contracting muscle in dogs and rabbits. J Physiol (1990) 0.81

Liver glycogen loading dampens glycogen synthesis seen in response to either hyperinsulinemia or intraportal glucose infusion. Diabetes (2012) 0.80

Pubertal stage and hypoglycaemia counterregulation in type 1 diabetes. Arch Dis Child (2005) 0.79

Insulin resistance in multiple tissues in patients with type 1 diabetes mellitus on long-term continuous subcutaneous insulin infusion therapy. Diabetes Metab Res Rev (2013) 0.79